Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts-Reference-Cited by-同舟云学术

Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts

Published:2018-01-29 Issue:1 Volume:13 Page:e0191574
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tutykhina Irina^ORCID,Esmagambetov Ilias,Bagaev Alexander,Pichugin Alexey,Lysenko Andrey,Shcherbinin Dmitry,Sedova Elena,Logunov Denis,Shmarov Maxim,Ataullakhanov Ravshan,Naroditsky Boris,Gintsburg Alexander

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Mortality associated with seasonal and pandemic influenza and respiratory syncytial virus among children <5 years of age in a high HIV prevalence setting—South Africa, 1998–2009;S Tempia;Clin Infect Dis,2014

2. Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic?;C Trombetta;Vaccines (Basel),2015

3. The influenza pandemic of 2009: lessons and implications;P Shapshak;Mol Diagn Ther,2011

4. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008;H Zhou;Clin Infect Dis,2012

5. Universal Influenza Vaccines, a Dream to Be Realized Soon;H Zhang;Viruses,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting the dimensions of universal vaccine with special focus on COVID-19: Efficacy versus methods of designing;International Journal of Biological Macromolecules;2024-10

2. An effective vaccine against influenza A virus based on the matrix protein 2 (M2);Veterinary Microbiology;2024-09

3. DNA and protein-generated chimeric molecules for delivery of influenza viral epitopes in mouse and humanized NSG transfer models;Human Vaccines & Immunotherapeutics;2024-01-09

4. Nucleoprotein as a Promising Antigen for Broadly Protective Influenza Vaccines;Vaccines;2023-11-23

5. Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus;Pharmaceutical Research;2023-06-21